Publications
- Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy2017 | Publication without faculty affiliation
- A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication2016 | Publication without faculty affiliation
- Novel 8-Hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer's disease2016 | Publication without faculty affiliation
- Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease2016 | Publication without faculty affiliation
- The antioxidant additive approach for Alzheimer's disease therapy: New ferulic (Lipoic) acid plus melatonin modified tacrines as Cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 activators2016 | Publication without faculty affiliation
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publication without faculty affiliation
- A Resurrection of 7-MEOTA: A Comparison with Tacrine2013 | Faculty of Pharmacy in Hradec Králové
- 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer's Disease Treatment - Synthesis, Biological Evaluation and Molecular Modeling Studies2013 | Publication without faculty affiliation
- Tacrine and its derivatives in the therapy of Alzheimer's disease2012 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
Loading network view...